OPKO Health Revenue 2012-2025 | OPK
OPKO Health revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
OPKO Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $713 |
| 2023 | $863 |
| 2022 | $1,004 |
| 2021 | $1,775 |
| 2020 | $1,435 |
| 2019 | $902 |
| 2018 | $990 |
| 2017 | $966 |
| 2016 | $1,117 |
| 2015 | $492 |
| 2014 | $91 |
| 2013 | $97 |
| 2012 | $47 |
| 2011 | $28 |
|
OPKO Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $152 |
| 2025-06-30 | $157 |
| 2025-03-31 | $150 |
| 2024-12-31 | $184 |
| 2024-09-30 | $174 |
| 2024-06-30 | $182 |
| 2024-03-31 | $174 |
| 2023-12-31 | $182 |
| 2023-09-30 | $179 |
| 2023-06-30 | $265 |
| 2023-03-31 | $238 |
| 2022-12-31 | $185 |
| 2022-09-30 | $180 |
| 2022-06-30 | $310 |
| 2022-03-31 | $329 |
| 2021-12-31 | $401 |
| 2021-09-30 | $386 |
| 2021-06-30 | $442 |
| 2021-03-31 | $545 |
| 2020-12-31 | $495 |
| 2020-09-30 | $428 |
| 2020-06-30 | $301 |
| 2020-03-31 | $211 |
| 2019-12-31 | $224 |
| 2019-09-30 | $229 |
| 2019-06-30 | $226 |
| 2019-03-31 | $222 |
| 2018-12-31 | $222 |
| 2018-09-30 | $250 |
| 2018-06-30 | $264 |
| 2018-03-31 | $255 |
| 2017-12-31 | $161 |
| 2017-09-30 | $246 |
| 2017-06-30 | $293 |
| 2017-03-31 | $266 |
| 2016-12-31 | $171 |
| 2016-09-30 | $298 |
| 2016-06-30 | $357 |
| 2016-03-31 | $291 |
| 2015-12-31 | $276 |
| 2015-09-30 | $143 |
| 2015-06-30 | $42 |
| 2015-03-31 | $30 |
| 2014-12-31 | $26 |
| 2014-09-30 | $20 |
| 2014-06-30 | $24 |
| 2014-03-31 | $22 |
| 2013-12-31 | $21 |
| 2013-09-30 | $21 |
| 2013-06-30 | $24 |
| 2013-03-31 | $31 |
| 2012-12-31 | $16 |
| 2012-09-30 | $12 |
| 2012-06-30 | $10 |
| 2012-03-31 | $9 |
| 2011-12-31 | $6 |
| 2011-09-30 | $7 |
| 2011-06-30 | $8 |
| 2011-03-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.998B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.627B | 27.76 |
| Intuitive Surgical (ISRG) | United States | $196.001B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $56.733B | 56.34 |
| Edwards Lifesciences (EW) | United States | $48.223B | 32.33 |
| IQVIA Holdings (IQV) | United States | $41.102B | 22.92 |
| Alcon (ALC) | Switzerland | $39.514B | 26.70 |
| Mettler-Toledo (MTD) | United States | $30.348B | 35.51 |
| DexCom (DXCM) | United States | $27.184B | 37.47 |
| STERIS (STE) | Ireland | $25.935B | 26.77 |
| Waters (WAT) | United States | $23.414B | 30.96 |
| Coloplast (CLPBY) | Denmark | $20.103B | 34.31 |
| Hologic (HOLX) | United States | $16.754B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| Globus Medical (GMED) | United States | $12.375B | 25.97 |
| Penumbra (PEN) | United States | $12.275B | 86.34 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.998B | 0.00 |
| TransMedics (TMDX) | United States | $4.851B | 57.47 |
| Teleflex (TFX) | United States | $4.554B | 7.26 |
| Veracyte (VCYT) | United States | $3.356B | 38.24 |
| LivaNova (LIVN) | United Kingdom | $3.323B | 17.95 |
| Integer Holdings (ITGR) | United States | $2.968B | 13.93 |
| Elekta AB (EKTAY) | Sweden | $2.412B | 22.57 |
| Alphatec Holdings (ATEC) | United States | $2.369B | 0.00 |
| Artivion (AORT) | United States | $2.013B | 92.39 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| Nihon Kohden (NHNKY) | Japan | $1.974B | 17.23 |
| PROCEPT BioRobotics (PRCT) | United States | $1.753B | 0.00 |
| AxoGen (AXGN) | United States | $1.421B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.415B | 0.00 |
| IRadimed (IRMD) | United States | $1.292B | 61.53 |
| Integra LifeSciences Holdings (IART) | United States | $0.976B | 5.29 |
| Pulse Biosciences (PLSE) | United States | $0.969B | 0.00 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.748B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.670B | 38.96 |
| Alpha Tau Medical (DRTS) | Israel | $0.636B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 10.99 |
| Mesa Laboratories (MLAB) | United States | $0.479B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.06 |
| Sight Sciences (SGHT) | United States | $0.364B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.327B | 2.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.186B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.145B | 0.00 |
| Solana (HSDT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.28 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |